Maxgalin ER 150 Tablet is a medicine used to relieve pain caused by nerve damage (neuropathic pain) due to diabetes, shingles (herpes zoster infection), spinal cord injury, or other conditions. It is also used to treat widespread muscle pain and stiffness in people with fibromyalgia.
“Baidyanath Swas Chintamani Ras (Vr) | For Respiratory Care” has been added to your cart. View cart
-10%

Maxgalin ER 100 Tablet
₹245.00 Original price was: ₹245.00.₹220.50Current price is: ₹220.50.

Enteroshield Vaccine
₹1,940.00 Original price was: ₹1,940.00.₹1,746.00Current price is: ₹1,746.00.
Maxgalin ER 150 Tablet
₹319.00 Original price was: ₹319.00.₹287.10Current price is: ₹287.10.
Maxgalin ER 150 Tablet is used to treat long-lasting (chronic) pain caused by nerve damage due to diabetes, shingles, or spinal cord injury. It reduces pain and its associated symptoms such as mood changes, sleep problems, and tiredness. It is thought to work by interfering with pain signals that travel through the damaged nerves and the brain.
Categories: Epilepsy, Healthcare, Nerve protecting, Pain Relief
Description
Reviews (0)
Be the first to review “Maxgalin ER 150 Tablet” Cancel reply
Related products
ARJUNA HIMALAYA
Baidyanath (Jhansi) Swarna Bhasma with Gold
Baidyanath Sundari Sakhi | For Weakness, Hormonal Imbalance & Menstrual Discomfort in Women
Baidyanath Swarna Maha Yograj Guggulu Tablet
Baidyanath Vita EX Gold Women Capsule
Dabur Amritarishta Syrup
The key ingredient Amrutha is known for its dosha-balancing properties and may help nourish the body tissues particularly (rasa and rakta dhatus)
The presence of Dashamoola (group of 10 roots) and Trikatu (dry ginger – pepper – long pepper) in this formulation may act on inflammatory conditions and the digestive system respectively
The formulation may also help to provide comfort in case of associated body aches and swollen joints
Ingredients like Trikatu and Musta improve digestion while Indrayava, Parpataka etc. help ama dosha (accumulated toxins) from the body
Reviews
There are no reviews yet.